Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Penn-Nicholson

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Plos Medicine|July 19, 2019
Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort studyAdam Penn-Nicholson, Thomas Hraha, Ethan G Thompson, et al.
Plos Medicine|April 17, 2019
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort studyAdam Penn-Nicholson, Thomas Hraha, Ethan G Thompson, et al.
The European Respiratory Journal|May 29, 2021
A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assaysAdam Penn-Nicholson, Sivaramakrishnan N Gomathi, Cesar Ugarte-Gil, et al.
Plos Pathogens|November 18, 2017
Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis diseaseThomas J Scriba, Adam Penn-Nicholson, Smitha Shankar, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
PERFORMANCE OF FUJILAM VERSION 1 FOR THE DIAGNOSIS OF TUBERCULOSIS IN CHILDREN UNDER 5 YEARS IN UGANDA - A BRIEF REPORTMirembe Angella Nanteza, Nelson Mukiza, Freddie Bwanga, et al.
Frontiers in Microbiology|July 13, 2019
Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral TherapyFatoumatta Darboe, Stanley Kimbung Mbandi, Kogieleum Naidoo, et al.
Cell Host & Microbe|June 16, 2017
Antigen Availability Shapes T Cell Differentiation and Function during TuberculosisAlbanus O Moguche, Munyaradzi Musvosvi, Adam Penn-Nicholson, et al.
BMC Infectious Diseases|August 15, 2024
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)Chacha Mangu, Marta Cossa, Robert Ndege, et al.
The Lancet. Infectious Diseases|January 28, 2021
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trialThomas J Scriba, Andrew Fiore-Gartland, Adam Penn-Nicholson, et al.
The Lancet. Global Health|April 16, 2021
Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy studySimon C Mendelsohn, Andrew Fiore-Gartland, Adam Penn-Nicholson, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Plos Medicine|July 19, 2019
Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort studyAdam Penn-Nicholson, Thomas Hraha, Ethan G Thompson, et al.
Plos Medicine|April 17, 2019
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort studyAdam Penn-Nicholson, Thomas Hraha, Ethan G Thompson, et al.
The European Respiratory Journal|May 29, 2021
A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assaysAdam Penn-Nicholson, Sivaramakrishnan N Gomathi, Cesar Ugarte-Gil, et al.
Plos Pathogens|November 18, 2017
Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis diseaseThomas J Scriba, Adam Penn-Nicholson, Smitha Shankar, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
PERFORMANCE OF FUJILAM VERSION 1 FOR THE DIAGNOSIS OF TUBERCULOSIS IN CHILDREN UNDER 5 YEARS IN UGANDA - A BRIEF REPORTMirembe Angella Nanteza, Nelson Mukiza, Freddie Bwanga, et al.
Frontiers in Microbiology|July 13, 2019
Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral TherapyFatoumatta Darboe, Stanley Kimbung Mbandi, Kogieleum Naidoo, et al.
Cell Host & Microbe|June 16, 2017
Antigen Availability Shapes T Cell Differentiation and Function during TuberculosisAlbanus O Moguche, Munyaradzi Musvosvi, Adam Penn-Nicholson, et al.
BMC Infectious Diseases|August 15, 2024
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)Chacha Mangu, Marta Cossa, Robert Ndege, et al.
The Lancet. Infectious Diseases|January 28, 2021
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trialThomas J Scriba, Andrew Fiore-Gartland, Adam Penn-Nicholson, et al.
The Lancet. Global Health|April 16, 2021
Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy studySimon C Mendelsohn, Andrew Fiore-Gartland, Adam Penn-Nicholson, et al.
Pageof 10